Matrix metalloprotease inhibitors. Summary and Table.
作者信息
Coleman S G
机构信息
Adis International Ltd., Auckland, New Zealand.
出版信息
Drugs R D. 1999 Feb;1(2):131-4. doi: 10.2165/00126839-199901020-00002.
Abstract
摘要
相似文献
1
Matrix metalloprotease inhibitors. Summary and Table.
Drugs R D. 1999 Feb;1(2):131-4. doi: 10.2165/00126839-199901020-00002.
2
Batimastat. BB 94, collagenase inhibitors-1.batimastat。BB 94，胶原酶抑制剂-1。
Drugs R D. 1999 Feb;1(2):139-41. doi: 10.2165/00126839-199901020-00005.
3
Omapatrilat.
Drugs R D. 1999 Apr;1(4):350-1. doi: 10.2165/00126839-199901040-00017.
4
AG 3340.
Drugs R D. 1999 Feb;1(2):137-8. doi: 10.2165/00126839-199901020-00004.
5
BAY12-9566. BAY 12 9566, BAY12 9566.
Drugs R D. 1999 Feb;1(2):142-3. doi: 10.2165/00126839-199901020-00006.
6
CGS 27023A. CDG 27023A.
Drugs R D. 1999 Feb;1(2):144-5. doi: 10.2165/00126839-199901020-00007.
7
Marimastat. BB 2516, TA 2516.
Drugs R D. 1999 Feb;1(2):146-9. doi: 10.2165/00126839-199901020-00008.
8
AE 941--Neovastat.
Drugs R D. 1999 Feb;1(2):135-6. doi: 10.2165/00126839-199901020-00003.
9
Endopeptidase inhibitors. Summary and table.
Drugs R D. 1999 Apr;1(4):339-40. doi: 10.2165/00126839-199901040-00012.
10
Clinical potential of matrix metalloprotease inhibitors.
Drugs R D. 1999 Feb;1(2):117-29. doi: 10.2165/00126839-199901020-00001.
引用本文的文献
1
Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.选择性基质金属蛋白酶抑制剂MMI-166与CPT-11联合使用时增强的抗转移疗效。
Clin Exp Metastasis. 2002;19(6):519-26. doi: 10.1023/a:1020321210623.
Zotero 插件